1-3 of 3
Anne Marie Maddox
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Study of Talabostat and Rituximab in Patients with Advanced Chronic Lymphoctyic Leukemia (CLL) Previously Treated with a Rituximab/Fludarabine Regimen.

Khuda D. Khan, MD, PhD, Susan O’Brien, MD, Kanti R. Rai, MD, Jennifer R. Brown, MD, PhD, Perry Cook, MD, Anne Marie Maddox, MD, Alison M. Duarte, MPH, Eric J. Haltom, Margaret J. Uprichard, PharmD
Journal: Blood
Blood (2005) 106 (11): 2125.
https://doi.org/10.1182/blood.V106.11.2125.2125
Published: 2005
Journal Articles

Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha

Clinical Trials & Observations
Peter McLaughlin, Elihu Estey, Armand Glassman, Jorge Romaguera, Felipe Samaniego, Ana Ayala, Kimberly Hayes, Anne Marie Maddox, H. Alejandro Preti, Fredrick B. Hagemeister
Journal: Blood
Blood (2005) 105 (12): 4573–4575.
https://doi.org/10.1182/blood-2004-08-3035
Published: 2005
Journal Articles

Myelodysplasia and Acute Myeloid Leukemia Following Therapy for Indolent Lymphoma with Fludarabine, Mitoxantrone, Dexamethasone (FND) Plus Rituximab and Interferon Alfa.

Peter McLaughlin, MD, Elihu Estey, MD, Armand Glassman, MD, Jorge Romaguera, MD, Felipe Samaniego, MD, PhD, Ana Ayala, RN, Kimberly Hayes, Anne Marie Maddox, MD, PhD, H. Alejandro Preti, MD, Fredrick B. Hagemeister, MD
Journal: Blood
Blood (2004) 104 (11): 1394.
https://doi.org/10.1182/blood.V104.11.1394.1394
Published: 2004